Equities

SkinBioTherapeutics PLC

SBTX:LSE

SkinBioTherapeutics PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)8.75
  • Today's Change0.25 / 2.94%
  • Shares traded235.81k
  • 1 Year change-30.00%
  • Beta2.3970
Data delayed at least 20 minutes, as of Jun 28 2024 15:36 BST.
More ▼
DateOpenHighLowCloseVolume
Friday, June 28, 2024Fri, Jun 28, 20248.759.008.648.75235,810235.81k
Thursday, June 27, 2024Thu, Jun 27, 20249.259.038.508.50326,652326.65k
Wednesday, June 26, 2024Wed, Jun 26, 20249.759.709.059.25117,822117.82k
Tuesday, June 25, 2024Tue, Jun 25, 20249.759.759.539.7548,70548.71k
Monday, June 24, 2024Mon, Jun 24, 20249.759.779.509.7522,13022.13k
Friday, June 21, 2024Fri, Jun 21, 20249.759.799.509.75173,167173.17k
Thursday, June 20, 2024Thu, Jun 20, 20249.759.799.509.75218,763218.76k
Wednesday, June 19, 2024Wed, Jun 19, 20249.759.899.589.75207,215207.22k
Tuesday, June 18, 2024Tue, Jun 18, 202410.0010.359.509.75694,623694.62k
Monday, June 17, 2024Mon, Jun 17, 20249.7510.009.579.75179,773179.77k
Friday, June 14, 2024Fri, Jun 14, 20249.759.859.509.75768,418768.42k
Thursday, June 13, 2024Thu, Jun 13, 20249.889.869.509.75175,952175.95k
Wednesday, June 12, 2024Wed, Jun 12, 20249.8810.259.709.88490,895490.90k
Tuesday, June 11, 2024Tue, Jun 11, 20249.8810.309.709.88949,004949.00k
Monday, June 10, 2024Mon, Jun 10, 20249.7510.249.509.76891,578891.58k
Friday, June 07, 2024Fri, Jun 07, 20249.8810.139.509.75616,178616.18k
Thursday, June 06, 2024Thu, Jun 06, 20249.8810.109.869.88506,799506.80k
Wednesday, June 05, 2024Wed, Jun 05, 20249.8810.259.859.88900,472900.47k
Tuesday, June 04, 2024Tue, Jun 04, 202410.0510.179.509.88185,251185.25k
Monday, June 03, 2024Mon, Jun 03, 20249.2510.509.3610.051,378,3321.38m
Friday, May 31, 2024Fri, May 31, 20249.259.389.009.25122,323122.32k
Data delayed at least 20 minutes, as of Jun 28 2024 16:36 BST.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.